Deerfield-Management-Company-Lp-Series-C

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
123
Total Value
5064779427
Accession Number
0001213900-25-044138
Form Type
13F-HR
Manager Name
Deerfield-Management-Company-Lp-Series-C
Data Enrichment
87% identified
107 identified16 unidentified

Holdings

123 positions • $5.1B total value
Manager:
Search and click to pin securities to the top
Page 2 of 7
DYNAVAX TECHNOLOGIES CORP
Shares:5.2M
Value:$67.3M
% of Portfolio:1.3% ($67.3M/$5.1B)
BAXTER INTERNATIONAL INC
Shares:1.9M
Value:$65.8M
% of Portfolio:1.3% ($65.8M/$5.1B)
Legend Biotech Corp
Shares:1.7M
Value:$59.2M
% of Portfolio:1.2% ($59.2M/$5.1B)
BIO-RAD LABORATORIES, INC.
Shares:226.1K
Value:$55.1M
% of Portfolio:1.1% ($55.1M/$5.1B)
IDEAYA Biosciences, Inc.
Shares:3.3M
Value:$53.5M
% of Portfolio:1.1% ($53.5M/$5.1B)
Edgewise Therapeutics, Inc.
Shares:2.1M
Value:$45.7M
% of Portfolio:0.9% ($45.7M/$5.1B)
Larimar Therapeutics, Inc.
Shares:21.2M
Value:$45.6M
% of Portfolio:0.9% ($45.6M/$5.1B)
Enhabit, Inc.
Shares:5.0M
Value:$43.9M
% of Portfolio:0.9% ($43.9M/$5.1B)
ALNYLAM PHARMACEUTICALS, INC.
Shares:145.0K
Value:$39.2M
% of Portfolio:0.8% ($39.2M/$5.1B)
BIOCRYST PHARMACEUTICALS INC
Shares:5.2M
Value:$38.9M
% of Portfolio:0.8% ($38.9M/$5.1B)
Disc Medicine, Inc.
Shares:782.3K
Value:$38.8M
% of Portfolio:0.8% ($38.8M/$5.1B)
CONMED Corp
Shares:611.0K
Value:$36.9M
% of Portfolio:0.7% ($36.9M/$5.1B)
516544AB9
Shares:
Value:$35.6M
% of Portfolio:0.7% ($35.6M/$5.1B)
Envista Holdings Corp
Shares:2.0M
Value:$35.0M
% of Portfolio:0.7% ($35.0M/$5.1B)
INSMED Inc
Shares:458.0K
Value:$34.9M
% of Portfolio:0.7% ($34.9M/$5.1B)
Embecta Corp.
Shares:2.7M
Value:$34.7M
% of Portfolio:0.7% ($34.7M/$5.1B)
16934W106
Shares:3.8M
Value:$32.1M
% of Portfolio:0.6% ($32.1M/$5.1B)
Pharvaris N.V.
Shares:2.0M
Value:$31.7M
% of Portfolio:0.6% ($31.7M/$5.1B)
Cullinan Therapeutics, Inc.
Shares:3.9M
Value:$29.2M
% of Portfolio:0.6% ($29.2M/$5.1B)
InMode Ltd.
Shares:1.6M
Value:$28.0M
% of Portfolio:0.6% ($28.0M/$5.1B)